emcure pharma ipo good or bad to invest?
Published 3 months ago • 24K plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
11:29
emcure pharmaceuticals ipo | apply or avoid?
-
9:19
✅ emcure pharma ipo review | emcure pharma ipo gmp analysis | emcure pharma se kitna listing gain mi
-
16:05
emcure pharma ipo summary | ca rachana ranade
-
12:03
emcure pharma vs bansal wire ipo review | share market investing
-
4:06
emcure pharma ipo: all you need to know before investing
-
25:00
jyothy labs' md talks about the future & legacy of the company | weekender | cnbc tv18
-
20:11
emcure pharmaceuticals ipo: growth plans, existing profit & more | all you need to know
-
16:52
sbfc finance ltd analysis : latest news, in-depth review & outlook with fundamentals & technical
-
19:33
everything you need to know about emcure pharmaceuticals ipo
-
8:00
emcure pharma ipo - opportunity or high valuation? | emcure pharma analysis |
-
0:59
emcure pharma lists at 31% premium over ipo price, management to focus on emerging markets
-
5:44
emcure pharma ipo launch: what to expect? market expert sneha poddar analysis the ipo debut
-
2:19
emcure pharma makes a stellar debut, lists at 31% premium to issue price | cnbc tv18
-
7:27
emcure pharmaceuticals ipo - apply or not? | emcure pharmaceuticals ipo review
-
19:30
will you invest in shark tank's namita thapar's company. emcure pharma ipo to open on july 3rd
-
3:00
emcure pharma ipo launches today; everything you need to know about the pharma company
-
1:20
who's behind the 25,000 crore emcure pharmaceuticals heading for ipo? i emcure pharma ipo
-
7:44
emcure pharma ipo to open next week, rationale behind the fundraise & utilization plans | et now
-
0:53
emcure pharma ipo listing: shares debut at nearly 32% premium over ipo price | n18s | cnbc tv18
-
0:58
kotak instl equities initiates coverage on emcure pharma with 'add' rating; target price of 1,655/sh
-
6:46
emcure pharma ipo lists at 30% premium | namita thapar & satish mehta share details | business news
-
8:30
emcure pharma ipo and bansal wire ipo - shocking | bank nifty and nifty analysis | 3/7/2024